SCHEMBL5790482

SCHEMBL5790482

Cc1ccc(NC(=O)c2sccc2NCc2ccnc3ccccc23)cc1N(N)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.60
CYP3A4 P08684 4/20 0.60
KIT P10721 2/20 0.60
RAF1 P04049 1/20 0.60
LCK P06239 1/20 0.60
RET P07949 1/20 0.60
MAP3K20 Q9NYL2 1/20 0.60
RIPK3 Q9Y572 1/20 0.60
FLT1 P17948 4/20 0.45
BRAF P15056 1/20 0.41
MAPK8 P45983 1/20 0.40
MAPK9 P45984 1/20 0.40
MAPK10 P53779 1/20 0.40
CYP2C19 P33261 4/20 0.37
CYP1A2 P05177 3/20 0.37
ALDH1A1 P00352 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5790468 0.86 KDR (0.63) KDRCYP3A4KITRAF1LCK
SCHEMBL5792920 0.86 KDR (0.68) KDRCYP3A4KITRAF1LCK
SCHEMBL5794547 0.85 KDR (0.60) KDRCYP3A4KITRAF1LCK
SCHEMBL633921 0.84 KDR (0.64) KDRCYP3A4KITRAF1LCK
SCHEMBL14044883 0.83 KDR (0.60) KDRCYP3A4KITRAF1LCK
SCHEMBL3745585 0.81 KDR (0.57) KDRCYP3A4KITRAF1LCK
SCHEMBL5792923 0.81 KDR (0.73) KDRCYP3A4KITRAF1LCK
SCHEMBL5792910 0.81 KDR (0.73) KDRCYP3A4KITRAF1LCK
SCHEMBL5794532 0.81 KDR (0.65) KDRCYP3A4KITRAF1LCK
SCHEMBL3745389 0.81 KDR (0.65) KDRCYP3A4KITRAF1LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006034110-A1 (ARYLAMIDOARYL) CYANOGUANIDINE COMPOUNDS AS INHIBITORS OF C-KIT PROTO-ONCOGENE OSI PHARMACEUTICALS, INC. (US) 2006-03-30 WO disclosed